STAT

JANUARY 21, 2024

LONDON — Starting Monday, a new, highly effective malaria vaccine will be rolled out for the first time, as an immunization campaign for children kicks off in Cameroon — a day that global health officials say marked a historic step in the decades-long quest to protect people from one of the world’s deadliest infections. The vaccine drive in Cameroon — the first launch of the vaccine outside of clinical trials and pilot programs — comes as some 20 African countr

Vaccines 145

Vaccines Immunization 145

Fierce Healthcare

JANUARY 21, 2024

Artificial intelligence dominated the conversation at the Consumer Electronics Show (CES) in Las Vegas earlier this month. | The health insurance giant, which serves 117 million people, sees opportunities to leverage generative AI and other technologies to make healthcare easier to navigate, chief AI officer Shawn Wang said during an interview at CES 2024.

Insurance 126

Insurance 126

Med Ed 101

JANUARY 21, 2024

There are so many inhalers on the market for asthma and COPD. LABA, LAMA, and ICS products are getting so hard to keep track of! Honestly, it gets a little overwhelming at times to remember them all by brand name and what category and classification they fall into. My good friend Derek Borkowski is the […] The post Inhaler Chart – Free PDF!

105

105

pharmaphorum

JANUARY 21, 2024

Bristol-Myers Squibb’s Opdivo-Yervoy regimen improves PFS as first-line therapy for patients with MSI-H/dMMR colorectal cancer in CheckMate-8HW trial

105

105

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

Pharmaceutical Technology

JANUARY 21, 2024

CDMOs, who cater to the requirements of multiple companies and develop platform processes to achieve the much-needed economy of scale, are being seen as a possible solution.

98

98

pharmaphorum

JANUARY 21, 2024

A vote by the HELP committee in the US on 31st January could result in the CEOs of Johnson & Johnson and Merck being forced to testify on drug pricing

101

101

Roots Analysis

JANUARY 21, 2024

With fourteen approved drugs and several drug candidates being evaluated under different stages of development, antibody drug conjugates (ADCs) are now recognized as a potent class of targeted therapeutics. The success of this relatively novel class of therapeutics is attributed to the ability of lead molecules to specifically identify and eliminate disease associated cells / pathogens, consequently, addressing most of the concerns related to off target toxicities.

40

40